Enhancing Betulinic Acid Dissolution Rate and Improving Antitumor Activity via Nanosuspension Constructed by Anti-Solvent Technique

References

• YogeeswariP, SriramD. Betulinic acid and its derivatives: a review on their biological properties. Curr Med Chem. 2005;12(6):657–666. doi:10.2174/092986705320221415790304
   PubMed Web of Science ®Google Scholar
• EiznhamerDA, XuZ. Betulinic acid: a promising anticancer candidate. IDrugs. 2004;7(4):359.15057642
   PubMed Web of Science ®Google Scholar
• KesslerJH, MullauerFB, de RooGM, et al. Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types. Cancer Lett. 2007;251(1):132–145. doi:10.1016/j.canlet.2006.11.00317169485
   PubMed Web of Science ®Google Scholar
• Oliveira CostaJF, Barbosa-FilhoJM, de Azevedo MaiaGL, et al. Potent anti-inflammatory activity of betulinic acid treatment in a model of lethal endotoxemia. Int Immunopharmacol. 2014;23(2):469–474. doi:10.1016/j.intimp.2014.09.02125281393
   PubMed Web of Science ®Google Scholar
• Holz-smithSL, SunIC, JinL, et al. Role of Human Immunodeficiency Virus (HIV) Type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564. Antimicrob Agents Ch. 2001;1(45):60–66. doi:10.1128/AAC.45.1.60-66.2001
   Web of Science ®Google Scholar
• SelzerE, PimentelE, WacheckV, et al. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells. J Invest Dermatol. 2000;114(5):935–940. doi:10.1046/j.1523-1747.2000.00972.x10771474
   PubMed Web of Science ®Google Scholar
• ChintharlapalliS, PapineniS, RamaiahSK, et al. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res. 2007;67(6):2816–2823. doi:10.1158/0008-5472.CAN-06-373517363604
   PubMed Web of Science ®Google Scholar
• FuldaS, FriesenC, LosM, et al. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res. 1997;57(21):4956–4964.9354463
   PubMed Web of Science ®Google Scholar
• ZucoV, SupinoR, RighettiSC, et al. Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett. 2002;175(1):17–25. doi:10.1016/S0304-3835(01)00718-211734332
   PubMed Web of Science ®Google Scholar
• FuldaS, KroemerG. Targeting mitochondrial apoptosis by betulinic acid in human cancers. Drug Discov Today. 2009;14(17–18): 885–890. doi:10.1016/j.drudis.2009.05.01519520182
   PubMed Web of Science ®Google Scholar
• ChengZ, ChenAF, WuF, et al. 8,8-Dimethyldihydroberberine with improved bioavailability and oral efficacy on obese and diabetic mouse models. Bioorg Med Chem. 2010;18(16):5915–5924. doi:10.1016/j.bmc.2010.06.08520663675
   PubMed Web of Science ®Google Scholar
• SanejaA, KumarR, SinghA, et al. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy. Int J Pharm. 2017;531(1):153–166. doi:10.1016/j.ijpharm.2017.08.07628823888
   PubMed Web of Science ®Google Scholar
• GuoBH, XuDQ, LiuXH, et al. Enzymatic synthesis and in vitro evaluation of folate-functionalized liposomes. Drug Des Devel Ther. 2017;11:1839–1847. doi:10.2147/DDDT.S132841
   PubMed Web of Science ®Google Scholar
• KumarP, SinghAK, RajV, et al. Poly(lactic-co-glycolic acid)-loaded nanoparticles of betulinic acid for improved treatment of hepatic cancer: characterization, in vitro and in vivo evaluations. Int J Nanomedicine. 2018;13:975–990. doi:10.2147/IJN.S15739129497292
   PubMed Web of Science ®Google Scholar
• MosharrafM, NyströmC. The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs. Int J Pharmaceut. 1995;122(1):35–47. doi:10.1016/0378-5173(95)00033-F
   Web of Science ®Google Scholar
• LouHY, GaoL, WeiXB, et al. Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice. Colloids Surf B. 2011;87(2):319–325. doi:10.1016/j.colsurfb.2011.05.037
   PubMed Web of Science ®Google Scholar
• KocbekP, BaumgartnerS, KristlJ. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int J Pharmaceut. 2006;312(1):179–186. doi:10.1016/j.ijpharm.2006.01.008
   PubMed Web of Science ®Google Scholar
• WangYC, MaYY, ZhengY, et al. In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity. Int J Pharmaceut. 2013;441(1–2):728–735. doi:10.1016/j.ijpharm.2012.10.021
   PubMed Web of Science ®Google Scholar
• ShenS, MamatM, ZhangSC. Synthesis of CaO2 nanocrystals and their spherical aggregates with uniform sizes for use as a biodegradable bacteriostatic agent. Small. 2019;15(36):1–7. doi:10.1002/smll.v15.36
   Web of Science ®Google Scholar
• VermaS, GokhaleR, BurgessDJ. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int J Pharmaceut. 2009;380(1–2):216–222. doi:10.1016/j.ijpharm.2009.07.005
   PubMed Web of Science ®Google Scholar
• ChavhanSS, PetkarKC, SawantKK. Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects. Crit Rev Ther Drug. 2011;28(5):447. doi:10.1615/CritRevTherDrugCarrierSyst.v28.i5
   PubMed Web of Science ®Google Scholar
• ChanHK, Chi Lip KwokP. Production methods for nanodrug particles using the bottom-up approach. Adv Drug Deliver Rev. 2011;63(6):406–416. doi:10.1016/j.addr.2011.03.011
   PubMed Web of Science ®Google Scholar
• ZhangHX, WangJX, ZhangZB, et al. Micronization of atorvastatin calcium by antisolvent precipitation process. Int J Pharmaceut. 2009;374(1–2):106–113. doi:10.1016/j.ijpharm.2009.02.015
   PubMed Web of Science ®Google Scholar
• GajeraBY, ShahDA, DaveRH. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology. Int J Pharmaceut. 2019;559:348–359. doi:10.1016/j.ijpharm.2019.01.054
   PubMed Web of Science ®Google Scholar
• JojoGM, KuppusamyG. Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer’s disease using Box-Behnken design. Drug Dev Ind Pharm. 2019;45(7):1061–1072. doi:10.1080/03639045.2019.159343930922126
   PubMed Web of Science ®Google Scholar
• RenLL, WangJJ, ChenGG. Preparation, optimization of the inclusion complex of glaucocalyxin A with sulfobutylether-β-cyclodextrin and antitumor study. Drug Deliv. 2019;26(1):309–317. doi:10.1080/10717544.2019.156862330896265
   PubMed Web of Science ®Google Scholar
• FerrariM, FornasieroMC, IsettaAM. MTT colorimetric assay for testing macrophage cytotoxic activity in vitro. J Immunol Methods. 1990;131(2):165. doi:10.1016/0022-1759(90)90187-Z2391427
   PubMed Web of Science ®Google Scholar
• KathpaliaH, JuvekarS, ShidhayeS. Design and in vitro evaluation of atovaquone nanosuspension prepared by pH based and anti-solvent based precipitation method. Colloid Interface Sci Commun. 2019;29:26–32. doi:10.1016/j.colcom.2019.01.002
   Web of Science ®Google Scholar
• CorneliaMK, RainerHM. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 2006;62(1):3–16. doi:10.1016/j.ejpb.2005.05.00916129588
   PubMed Web of Science ®Google Scholar
• ArunkumarN, DeecaramanM, RaniC. Nanosuspension technology and its applications in drug delivery. Asian J Pharm. 2009;3(3):168. doi:10.4103/0973-8398.56293
   Google Scholar
• JägerS, WinklerK, PfüllerU, et al. Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of viscum L. Planta Med. 2007;73(2):157–162. doi:10.1055/s-2007-96710617415876
   PubMed Web of Science ®Google Scholar
• GaoY, LiZG, SunM, et al. Preparation and characterization of intravenously injectable curcumin nanosuspension. Drug Deliv. 2011;18(2):131–142. doi:10.3109/10717544.2010.52035320939679
   PubMed Web of Science ®Google Scholar
• SharmaP, GargS. Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs. Adv Drug Deliver Rev. 2010;62(4–5):491–502. doi:10.1016/j.addr.2009.11.019
   PubMed Web of Science ®Google Scholar
• DuH, ChenXQ. CD-MEKC method to analyze triterpene acids in traditional Chinese medicines. J Braz Chem Soc. 2009;20(7):1268–1274. doi:10.1590/S0103-50532009000700011
   Web of Science ®Google Scholar
• HintzRJ, JohnsonKC. The effect of particle size distribution on dissolution rate and oral absorption. Int J Pharm. 1989;51:9–17. doi:10.1016/0378-5173(89)90069-0
   Web of Science ®Google Scholar
• MohammadA, AbdulhameedAS, JawadAH. Box-Behnken design to optimize the synthesis of new crosslinked chitosan-glyoxal/TiO2 nanocomposite: methyl orange adsorption and mechanism studies. Int J Biol Macromol. 2019;129:98–109. doi:10.1016/j.ijbiomac.2019.02.02530735780
   PubMed Web of Science ®Google Scholar
• KumarM, DahujaA, SachdevA, et al. Valorisation of black carrot pomace: microwave assisted extraction of bioactive phytoceuticals and antioxidant activity using Box-Behnken design. J Food Sci Technol. 2019;56(2):995–1007. doi:10.1007/s13197-018-03566-930906057
   PubMed Web of Science ®Google Scholar
• MeerlooJV, KaspersGJL. Cell sensitivity assays: the MTT assay. Methods Mol Biol. 2011;(731):237–245.
   PubMedGoogle Scholar
• HongEH, SongJH, KangKB, et al. Anti-influenza activity of betulinic acid from Zizyphus jujuba on influenza A/PR/8 virus. Biomol Ther. 2015;23(4):345–349. doi:10.4062/biomolther.2015.019
   PubMed Web of Science ®Google Scholar